510(k) device
Nofact VIII
R2 Diagnostics, Inc. · Plasma, Coagulation Factor Deficient (GJT, Class II) · First FDA decision Dec 19, 2011, newest Dec 19, 2011Anemia, clotting and blood disorders
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Nofact VIII"
MAUDE reports
0
Brand "Nofact VIII", since 2015
PubMed studies
0
Mentioning "Nofact VIII"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Nofact VIII
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- NOFACT VIII510(k)
K102851 · Decided Dec 19, 2011 · 446 days after receipt
Device type: Plasma, Coagulation Factor Deficient (GJT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Nofact VIII", any status and sponsor, newest update first.
No registered device study names "Nofact VIII".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Nofact VIII", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code GJT
11 reports: 11 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Nofact VIII"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code GJT.
- HemosIL Factor XII Deficient PlasmaInstrumentation Laboratory CO · 510(k) 2018
- CRYOcheck Factor VIII Deficient Plasma with VWFPrecision Biologic, Inc. · 510(k) 2023
- Nofact IXR2 Diagnostics, Inc. · 510(k) 2011
- Diapharma Factor X KitDiapharma Group, Inc. · 510(k) 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.